Status:
UNKNOWN
Ticopa Serum Analysis: an Analysis of Blood Samples From the TICOPA Study
Lead Sponsor:
University of Leeds
Conditions:
Psoriatic Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
A range of different drugs are available to treat psoriatic arthritis (PsA) inflammation. However, clinicians are unable to predict who will respond well to a given drug, who will fail to respond and ...
Detailed Description
1. INTRODUCTION 1.1. Background Psoriatic Arthritis (PsA) is estimated to occur in 10-15% of individuals with psoriasis, and accounts for 13% of people attending early arthritis clinics.Two thirds of ...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- \- treatment naive patients with early psoriatic arthritis
- Exclusion Criteria
- previous treatment with systemic therapy
- other inflammatory arthritis
Exclusion
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2024
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT05329896
Start Date
April 1 2022
End Date
March 31 2024
Last Update
April 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Leeds
Leeds, United Kingdom, LS9 4NZ